Fevipiprant CAS 872365-14-5: Advanced Anti-Hair Loss Solution with High Purity
Discover the potent CRTh2 receptor antagonist for advanced hair loss treatments.
Get a Quote & SampleProduct Core Value
Fevipiprant Powder
Fevipiprant (CAS 872365-14-5) is a highly pure (99%) pharmaceutical intermediate, functioning as a selective, potent, and reversible competitive antagonist for the CRTh2 receptor. Its low KD value of 1.1 nM and IC50 of 0.44 nM make it exceptionally effective in modulating eosinophil activity, offering a promising solution for various inflammatory conditions, including its application in anti-hair loss treatments.
- Explore the benefits of Fevipiprant CAS 872365-14-5 for your pharmaceutical research. This potent compound offers targeted action for effective results.
- Investigate Fevipiprant as a key pharmaceutical intermediate in the development of novel therapies for hair loss and other inflammatory conditions.
- Experience the high purity of Fevipiprant Powder, ensuring reliable and consistent performance in your formulations.
- Leverage the capabilities of a selective CRTh2 receptor antagonist for advanced dermatological applications.
Product Advantages
High Purity and Potency
Achieve superior efficacy with our Fevipiprant, boasting 99% purity and potent CRTh2 receptor antagonism, crucial for developing effective anti-hair loss treatments.
Targeted Mechanism of Action
Understand the precise action of Fevipiprant as a selective antagonist, essential for mitigating inflammation associated with hair loss and other dermatological issues.
Reliable Supply Chain
Benefit from a stable supply with a lead time of 10-15 days, ensuring your research and production schedules remain on track.
Key Applications
Anti-Hair Loss Treatments
Fevipiprant's ability to target specific inflammatory pathways makes it a valuable ingredient in advanced formulations designed to combat hair loss.
Pharmaceutical Research
As a high-purity pharmaceutical intermediate, Fevipiprant is ideal for scientific research and the development of new therapeutic agents.
Dermatological Innovations
Explore the potential of Fevipiprant in developing innovative treatments for skin conditions where eosinophil activity is a factor.
Chemical Synthesis
Utilize this precise chemical compound in synthesis processes requiring high specificity and purity.
Related Technical Articles & Resources
Why Choose Us?
Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.
Global Experience
With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.
Advanced Facilities
Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.
Seamless Scalability
We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).